Publications
Publications
Show Results For
- All HBS Web
(667)
- Faculty Publications (162)
- December 2008 (Revised January 2011)
- Case
Arcadia Biosciences: Seeds of Change
By: Arthur A. Daemmrich, Forest L. Reinhardt and Mary Louise Shelman
Arcadia Biosciences is an entrepreneurial California agricultural biotech company seeking to earn carbon credits by modifying commodity crops for use in China and India. Eric Rey, Arcadia's CEO, faced a strategic inflection point in early September 2008. The company... View Details
- 2008
- Working Paper
Opening Platforms: How, When and Why?
By: Thomas R. Eisenmann, Geoffrey Parker and Marshall Van Alstyne
Platform-mediated networks encompass several distinct types of participants, including end users, complementors, platform providers who facilitate users' access to complements, and sponsors who develop platform technologies. Each of these roles can be opened-that... View Details
- August 2008 (Revised December 2009)
- Case
Nantero
By: William A. Sahlman, Dan Heath and Caroline Perkins
This case describes a decision confronting the founder of Nantero, a company developing a new semiconductor technology. The company needs to raise additional venture capital. Potential investors have competing visions for the company, and its business model. Some... View Details
- July 2008 (Revised February 2009)
- Case
(PRODUCT) RED (A)
By: Youngme E. Moon, Michael I. Norton and David Chen
Describes the launch and initial results of the (PRODUCT) RED campaign, a social marketing initiative conceived by U2's Bono and Bobby Shriver to combat AIDS in sub-Saharan Africa. The company licensed the (RED) brand to partner companies, which initially included Gap,... View Details
- May 2008 (Revised March 2010)
- Case
Palm (A): The Debate on Licensing Palm's OS (1997)
By: Ramon Casadesus-Masanell, Kevin Boudreau and Jordan Mitchell
This case series looks at three important inflection points in Palm's history that relate to decisions about its platform: when the company was debating whether to open its operating system (OS) for licensing to third-party hardware manufacturers; 2001, when the... View Details
- May 2008 (Revised March 2010)
- Supplement
Palm (B): 2001
By: Ramon Casadesus-Masanell, Kevin Boudreau and Jordan Mitchell
This case series looks at three important inflection points in Palm's history that relate to decisions about its platform: when the company was debating whether to open its operating system (OS) for licensing to third-party hardware manufacturers; 2001, when the... View Details
- May 2008 (Revised March 2010)
- Supplement
Palm (C): 2005
By: Ramon Casadesus-Masanell, Kevin Boudreau and Jordan Mitchell
This case series looks at three important inflection points in Palm's history that relate to decisions about its platform: when the company was debating whether to open its operating system (OS) for licensing to third-party hardware manufacturers; 2001, when the... View Details
- May 2008 (Revised March 2010)
- Supplement
Palm (D): Epilogue as of 2008
By: Ramon Casadesus-Masanell, Kevin Boudreau and Jordan Mitchell
This case series looks at three important inflection points in Palm's history that relate to decisions about its platform: when the company was debating whether to open its operating system (OS) for licensing to third-party hardware manufacturers; 2001, when the... View Details
- March 2008 (Revised February 2009)
- Case
Transparent Value LLC
By: Sharon P. Katz, Krishna G. Palepu and Aldo Sesia, Jr.
Leading index company Dow Jones recently signed a license and joint marketing agreement with Transparent Value LLC, the creator of a new fundamentals-based valuation methodology. The agreement allowed Dow Jones to offer a family of indexes based on the Transparent... View Details
Keywords: Asset Management; Stocks; Price; Performance Expectations; Mathematical Methods; Valuation
- February 2008 (Revised May 2011)
- Case
The Travails of Rubber: Goodyear or Badyear?
By: Tom Nicholas and Andrew Ferguson
Explores the reason why Charles Goodyear, inventor of rubber vulcanization, was unable to profit from his discovery despite securing international property rights over his invention through a patent in 1844. Considers the utility of patents as an incentive for... View Details
- October 2007
- Article
The Art of Designing Markets
By: Alvin E. Roth
Traditionally, markets have been viewed as simply the confluence of supply and demand. But to function properly, they must be able to attract a sufficient number of buyers and sellers, induce participants to make their preferences clear, and overcome congestion by... View Details
- September 2007 (Revised May 2009)
- Case
Syndexa and Technology Transfer at Harvard University
By: Richard G. Hamermesh and David Kiron
Gokhan Hotamisligil is a star researcher at Harvard School of Public Health who has made groundbreaking discoveries linking fat cells, inflammation, and diabetes. He now wants to form a company to commercialize these discoveries. At the same time, Isaac Kohlberg, the... View Details
- fall 2007
- Article
The Design of Patent Pools: The Determinants of Licensing Rules
By: Josh Lerner, Marcin Strojwas and Jean Tirole
Patent pools are an important but little-studied economic institution. In this paper, we first make a set of predictions about the licensing terms associated with patent pools. The theoretical framework predicts that (a) pools consisting of complementary patents are... View Details
- August 2007
- Module Note
Managing Networked Businesses: Platform Evolution Module
Offers an overview of conceptual content and pedagogical guidance for instructors using a six-session module, "Platform Evolution," from "Managing Networked Businesses" (MNB), a case-based MBA elective course on platform-mediated networks. The module explores the... View Details
- May 2007 (Revised September 2008)
- Case
Biocon Limited
By: Krishna G. Palepu and Ananth Chepuri
Biocon Limited was facing significant pricing pressure in their cash cow business, that primarily consisted of manufacturing Active Pharmaceutical Ingredients (APIs). To combat this commoditization, Biocon's leadership had chosen an innovation-led strategy. This new... View Details
- January 2007
- Background Note
Note on Biotech Business Development
By: Richard G. Hamermesh and Robert F. Higgins
Describes the business development process in biotechnology companies. Topics covered include: participants in the licensing process and their interests, the major steps in the licensing process, the terms that are part of most agreements, and the most contentious... View Details
- December 2006 (Revised October 2007)
- Case
Monsanto: Realizing Biotech Value in Brazil
By: David E. Bell and Mary L. Shelman
In 2003, Monsanto's patented "Roundup Ready" technology was used illegally on 70-80% of the soybean area in southern Brazil. Under pressure from U.S. soybean growers, who were paying to license the technology, the firm implemented an innovative delivery-based... View Details
- November 2006 (Revised March 2007)
- Case
Liz Claiborne and the New Working Woman
By: Anthony Mayo and Mark Benson
At age 47, with two decades of experience as a lead designer for a Fortune 500 fashion company, Liz Claiborne put her life savings on the line to form Liz Claiborne, Inc., a partnership that included her husband. A decade later, in 1986, Claiborne was CEO of her own... View Details
- October 2006 (Revised August 2007)
- Case
RKS Guitars
By: Elie Ofek, Thomas J. Steenburgh, Michael I. Norton and Kerry Herman
RKS has designed a revolutionary electric guitar and needs to decide how to best market their innovation. The iconic status of existing electric guitars, and the lack of any recent radical innovations in the category, pose challenges in securing consumer adoption. If... View Details